Aberrant regulation of Nemo-like kinase and its disruption elicits regression of tumor cell growth by cyclin D1 and CDK2 suppression in human hepatocellular carcinoma

被引：0
|
作者：
Jung, Kwang Hwa
Kim, Jeong Kyu
Noh, Ji Heon
Eun, Jung Woo
Bae, Hyun Jin
Xie, Hong Jian
Park, Won Sang
Lee, Jung Young
Nam, Suk Woo
机构：
[1] Catholic Univ Korea, Dept Pathol, Coll Med, Seoul 137701, South Korea
[2] Catholic Univ Korea, Microdissect Genom Res Ctr, Seoul 137701, South Korea
来源：
MOLECULAR & CELLULAR TOXICOLOGY | 2009年 / 5卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 38 条
  • [21] Involvement of p21WAF1/Cip1, p27Kip1, CDK2, CDK4, CDC2, cyclin A and cyclin B1 and map kinase signal pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines.
    Cheng, J
    Imanishi, H
    Liu, WD
    Iwasaki, A
    Nakamura, H
    Yamanaka, J
    Fujimoto, J
    Hada, T
    HEPATOLOGY, 2003, 38 (04) : 597A - 597A
  • [22] BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1 (vol 35, pg 2382, 2016)
    Tu, Kangsheng
    Liu, Zhikui
    Yao, Bowen
    Xue, Yumo
    Xu, Meng
    Dou, Changwei
    Yin, Guozhi
    Wang, Jun
    ONCOLOGY REPORTS, 2023, 49 (01)
  • [23] Suppression of histone deacetylase 2 elicits cell-cycle arrest through the induction of p21waf1/CIP1 followed by transcriptional inhibition of CDK2/cyclin E complex in A549 human lung carcinoma cells
    Lung, Kwang Hwa
    Noh, Ji Heon
    Eun, Jung Woo
    Kim, Jeong Kyu
    Bae, Hyun Jin
    Jian, Xie Hong
    Lee, Sug Hyung
    Park, Won Sang
    Yoo, Nam Jin
    Lee, Lung Young
    Nam, Suk Woo
    MOLECULAR & CELLULAR TOXICOLOGY, 2007, 3 (04) : 40 - 40
  • [24] Evaluation of Cyclin D1 and Human Epidermal Growth Factor Receptor 2 Neu Protein Expression in Head and Neck Squamous Cell Carcinoma
    Sinha, Snigdha
    Das, Subhashish
    Mohiyuddin, S. M. Azeem
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (02)
  • [25] Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter
    Xiangning Zhang
    Hui Liu
    Binbin Li
    Peichun Huang
    Jianyong Shao
    Zhiwei He
    BMC Cancer, 12
  • [26] Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter
    Zhang, Xiangning
    Liu, Hui
    Li, Binbin
    Huang, Peichun
    Shao, Jianyong
    He, Zhiwei
    BMC CANCER, 2012, 12
  • [27] PSMC2 Regulates Cell Cycle Progression Through the p21/Cyclin D1 Pathway and Predicts a Poor Prognosis in Human Hepatocellular Carcinoma
    Liu, Yiwei
    Chen, Hairong
    Li, Xiangcheng
    Zhang, Feng
    Kong, Lianbao
    Wang, Xuehao
    Bai, Jin
    Wu, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [28] Histone acetylation activated-IGF2BP3 regulates cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma
    Zhou, Tao
    Zhu, Xiaoxiao
    Ji, Xiaoying
    He, Jinli
    Zhao, Kunming
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2025, 306
  • [29] Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor κB activation
    Ozaki, Iwata
    Zhang, Hao
    Mizuta, Toshihiko
    Ide, Yasushi
    Eguchi, Yuichiro
    Yasutake, Tsutomu
    Sakamaki, Toshiyuki
    Pestell, Richard G.
    Yamamoto, Kyosuke
    CLINICAL CANCER RESEARCH, 2007, 13 (07) : 2236 - 2245
  • [30] Targeted-disruption of histone deacetylase 2 suppresses cell growth through transcriptional induction of p21WAF1/CIP1 and inhibition of cyclin E2/CDK2 complex in human lung cancer cells
    Jung, Kwang Hwa
    Noh, Ji Heon
    Kim, Jeong Kyu
    Eun, Jung Woo
    Bae, Hyun Jin
    Xie, Hongjian
    Park, Wong Sang
    Lee, Jung Young
    Nam, Suk Woo
    CANCER RESEARCH, 2009, 69
1234